期刊
BRIEFINGS IN BIOINFORMATICS
卷 22, 期 5, 页码 -出版社
OXFORD UNIV PRESS
DOI: 10.1093/bib/bbab058
关键词
survival interaction; biomarker; immune cell; drug combination
资金
- National Natural Science Foundation of China [81602620, 81803431, 81700540, 81830054, 91859205, 81988101, 82073307]
- Shanghai Education Commission [201901070007E00065]
siGCD is a web-based tool for analyzing and visualizing the survival interaction of Genes, Cells and Drugs in human cancers. It utilizes cancer heterogeneity to simulate the manipulated gene expression, cell infiltration, and drug treatment.
It is pivotal and remains challenge for cancer precision treatment to identify the survival outcome interactions between genes, cells and drugs. Here, we present siGCD, a web-based tool for analysis and visualization of the survival interaction of Genes, Cells and Drugs in human cancers. siGCD utilizes the cancer heterogeneity to simulate the manipulated gene expression, cell infiltration and drug treatment, which overcomes the data and experimental limitations. To illustrate the performance of siGCD, we identified the survival interaction partners of EGFR (gene level), T cells (cell level) and sorafenib (drug level), and our prediction was consistent with previous reports. Moreover, we validate the synergistic effect of regorafenib and glyburide, and found that glyburide could significantly improve the regorafenib response. These results demonstrate that siGCD could benefit cancer precision medicine in a wide range of advantageous application scenarios including gene regulatory network construction, immune cell regulatory gene identification, drug (especially multiple target drugs) response biomarker screening and combination therapeutic design.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据